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Abstract
Interleukin-2 (IL-2) is a multi-faceted cytokine, known for promoting proliferation, survival, and cell death depending on the
cell type and state. For example, IL-2 facilitates cell death only in activated T cells when antigen and IL-2 are abundant. The
availability of IL-2 clearly impacts this process. Our laboratory recently demonstrated that IL-2 is retained in blood vessels by
heparan sulfate, and that biologically active IL-2 is released from vessel tissue by heparanase. We now demonstrate that
heparanase digestion also releases a dimeric form of IL-2 that is highly cytotoxic to cells expressing the IL-2 receptor. These
cells include ‘‘traditional’’ IL-2 receptor-bearing cells such as lymphocytes, as well as those less well known for IL-2 receptor
expression, such as epithelial and smooth muscle cells. The morphologic changes and rapid cell death induced by dimeric
IL-2 imply that cell death is mediated by disruption of membrane permeability and subsequent necrosis. These findings
suggest that IL-2 has a direct and unexpectedly broad influence on cellular homeostatic mechanisms in both immune and
non-immune systems.
Citation: Wrenshall LE, Clabaugh SE, Cool DR, Arumugam P, Grunwald WC, et al. (2014) Identification of a Cytotoxic Form of Dimeric Interleukin-2 in Murine
Tissues. PLoS ONE 9(7): e102191. doi:10.1371/journal.pone.0102191
Editor: David D. Roberts, Center for Cancer Research, National Cancer Institute, United States of America
Received November 12, 2013; Accepted June 16, 2014; Published July 14, 2014
Copyright:  2014 Wrenshall et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was supported by the following: 1. Miami Valley Hospital Foundation www.mvhfoundation.org; 2. NIH grant # R21 HL102589-03. The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* Email: lucile.wrenshall@wright.edu
¤ Current address: Advanced Testing Laboratory, Cincinnati, Ohio, United States of America
Introduction
Interleukin-2 (IL-2) is a fascinating cytokine, with widely varying
functions including promotion of apoptosis, proliferation and
survival of lymphocytes [1]. Not surprisingly, these varied
responses depend on the type of lymphocyte, and on the activation
state of the cell. Apoptosis, for example, occurs in activated T cells
that are exposed to IL-2 and then re-activated [2]. This activation-
induced cell death (recently renamed restimulation-induced cell
death) is thought to be a feedback mechanism designed to limit the
expansion and facilitate the down-regulation of antigen-specific
immune responses [3]. The importance of restimulation-induced
cell death is demonstrated by IL-2 knock out mice, which develop
a lethal lympho-proliferative phenotype and autoimmunity [4].
While IL-2 is typically considered a monomeric protein, studies
by Eitan, et al described a dimeric form of IL-2 that was cytotoxic
to oligodendrocytes [5]. This dimeric IL-2, extracted from fish
optic neurons, was thought to be the result of the cross-linking of
two IL-2 monomers by optic nerve-derived transglutaminase. This
hypothesis was based on data demonstrating that recombinant
human IL-2 also formed a cytotoxic dimer after exposure to the
same transglutaminase [6]. Dimeric IL-2 was shown to induce
apoptosis of oligodendrocytes after several hours, likely through a
p53-related mechanism [7].
Our laboratory recently reported that IL-2 is retained in the
blood vessel wall by heparan sulfate [8,9] Specifically, we showed
that heparanase digestion of murine aortic tissue resulted in the
release of biologically active, monomeric (15 kD) IL-2 [8].
Interestingly, heparanase digestion also resulted in the release of
a 30 kD (dimeric) form of IL-2. The dimeric form of IL-2 was
isolated from murine aortas and found to be cytotoxic to several
different cell types expressing the IL-2 receptor. In contrast to the
studies by Eitan, et al, the onset of cell death was rapid and dimer-
treated cells appeared to be dying by oncosis, which is
characterized by a loss of membrane integrity and cellular swelling
[10]. These results demonstrate that dimeric IL-2 is present
endogenously in mammalian tissues and suggests that so
positioned, dimeric IL-2 may function to restrict excess prolifer-
ation under pro-inflammatory conditions in vivo.
Materials and Methods
Materials and cell lines
Murine aortas were obtained from Balb/c mice. Small sections
of human iliac artery were obtained from deceased donor organs.
Heparinase I and chemical reagents, unless otherwise indicated,
were obtained from Sigma-Aldrich (St. Louis, MO). Alpha-Cyano-
4-Hydroxy-Cinnamic Acid (CHCA) MALDI Matrix was from
Thermo Scientific (Waltham, MA). Recombinant mouse IL-2 was
from Cell Sciences (Canton, MA). The fluorescent dye used to
label IL-2 (800CW) was obtained from LI-COR Biosciences
(Lincoln, NE). CellTox Green cytotoxicity and CellTiterGlo
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proliferation assays were from Promega (Madison, WI). LDH
cytotoxicity assay was from Roche (Indianapolis, IN). The
following antibodies were used: rabbit anti-mouse/human IL-2
receptor (IL-2R) bpolyclonal antibody (Novus Biologicals, Lit-
tleton, CO), mouse anti-rat IL-2Rb monoclonal antibody (clone
L316, AbD Serotec, Raleigh, NC), rat anti-mouse blocking
monoclonal antibody (clone S4B6, BD Biosciences, San Jose,
CA), and a chicken polyclonal antibody recognizing human and
murine IL-2 (Sigma). CTLL-2 (mouse cytotoxic T lymphocyte),
NRK (normal rat kidney epithelium), HK-2 (human kidney
epithelium), B16-F10 (mouse melanoma) cells, and EL4.IL-2
(murine lymphoma) cell lines were obtained from American Tissue
Type Collection (Manassas, VA). Smooth Muscle Cell Medium
was from ScienCell (Carlsbad, CA).
Ethics statement
Mice were housed and treated in strict accordance with
protocols approved by the Wright State University Laboratory
Animal Care and Use Committee (AUP # 891). Authorization for
use of donated human tissue for research was obtained from the
donor (primary authorization) or next of kin. Tissues were
provided by Life Connection of Ohio (www.lifeconnectionofohio.
org). Human subjects are defined as living individuals and
therefore use of these tissues is exempt from Institutional Review
Board review at Wright State University. Human vascular smooth
muscle cells were grown in accordance with protocols approved by
the Institutional Biosafety Committee (IBC# 230).
Dye-labeled IL-2
Murine IL-2 (R & D Systems) was covalently conjugated to an
activated infrared dye (800CW, LI-COR) per the manufacturer’s
instructions. Briefly, activated dye was added to the IL-2 at a
molar ratio of 1:1. Following a 2 hour incubation at 24uC,
unconjugated dye was removed from the preparation using a de-
salting column. The concentration of the dye-conjugated IL-2 was
then determined by Bradford assay (Sigma). To confirm conjuga-
tion of the IL-2 to the 800CW dye, 0.5 mg of dye-IL-2 was
separated by SDS-PAGE, transferred to nitrocellulose, and
analyzed on an Odyssey infrared scanner (LI-COR Biosciences).
Cytotoxicity assays
Human vascular smooth muscle cells (VSMC) were incubated
with dimeric IL-2 at the times and concentrations indicated in the
figure legends. Cell death was assessed by either LDH release or
by fluorescence of a DNA-binding dye (CellTox Green). For
assessment of LDH release, cell culture media (80 mL/well) was
harvested and centrifuged at 4,000 rpm for 10 minutes to remove
debris. LDH activity in the supernatants was quantified using a
commercially available kit (Roche). CellTox Green, designed to
assess cell death kinetically, was added just prior to or simulta-
neously with dimeric IL-2 or vehicle control. Absorbance or
fluorescence was read at the appropriate wavelength using a
Synergy H1 microplate reader (Biotek, Winooski, VT). In select
experiments, cells were pre-incubated for 15 minutes with blocking
anti-IL-2Rb (rabbit anti-human polyclonal, Novus) or anti-IL-2
antibodies (S4B6, BD Biosciences).
CTLL-2 assay
CTLL-2 cells were cultured in RPMI-1640 media with 10%
FBS. For bioassay, cells were plated in 96 well plates at
56104 cells/ml, and cultured with increasing concentrations of
IL-2 for 24 h at 37uC. Proliferation was assessed by ATP content
per manufacturer’s instructions (CellTiterGlo).
Isolation of dimeric IL-2 from tissues or media
Murine aortas were cleaned of adventitia and adipose, cut into
,1 mm3 pieces, and homogenized in ice-cold in urea extraction
buffer (8 M urea, 100 mM Tris-HCl, pH 7.5). The extracts were
sonicated on ice and then clarified by centrifugation. The resultant
supernatants were separated by reducing SDS-PAGE (3–15%
gradient; Bio-Rad) and then subjected to negative zinc staining
(Bio-Rad). Using a companion Western blot of the extract probed
with a chicken polyclonal anti-IL-2 antibody (Sigma) as a guide,
the 30 kD bands were excised and electro-eluted (Bio-Rad). Eluted
samples were pooled, dialysed over a period of 48 hours with four
buffer exchanges, concentrated by dialysis against aquacide II
(Calbiochem) or ammonium sulfate precipitation, then re-
suspended in storage buffer (TBS without Ca or Mg) and stored
at 4C. The amount of dimeric IL-2 isolated was quantified by
Western blot analysis with a chicken polyclonal anti-IL-2 antibody
(Sigma) incorporating scanning densitometry and a standard curve
of known concentrations of monomeric IL-2.
EL4.IL-2 cells were stimulated for 48 h with 1 mg/ml PHA and
10 ng/ml PMA. The supernatant was collected, passed through
an Amicon filter (0.2 mM), then subjected to reducing SDS-PAGE
and electro-elution as described above. Isolation of 30 kD IL-2
was verified by Western blot analysis and quantified by scanning
densitometry.
Vascular smooth muscle cell cultures
Human vascular smooth muscle cells (VSMC) were isolated
from pieces of aorta using a modification of a previously reported
technique [11]. Briefly, approximately 1 cm pieces of aorta were
washed with PBS and all adipose was removed. The artery was
sliced to open the lumen, and small (1 mm62 mm) pieces were cut
and placed lumen side down into a 75 cm tissue culture flask (6–8
pieces per flask). The tissue (without media) was incubated at 37uC
for 3–4 h to allow the tissue to dry and adhere to the flask. Ten mls
of SMC media (ScienCell) were carefully added to the flask so as
not to dislodge the pieces of aorta. The tissue was maintained at
37uC and SMCs were harvested in 3–4 weeks. VSMC were then
passaged every 7 days and used after 4 passages [8].
Western blot analysis
Western blot analysis of supernatants was performed as follows.
EL4.IL2 supernatants were generated as described above. An
equal volume of 2X Laemmli running buffer (Bio-Rad, Hercules,
CA) containing 5% v/v b-mercaptoethanol (Bio-Rad) was added
to the media which was then separated by sodium dodecyl sulfate
polyacrylamide gel electrophoresis (SDS-PAGE) on 10% gels (Bio-
Rad), transferred to 0.2 mm nitrocellulose (Bio-Rad), blocked with
Tris-buffered saline (TBS) with 0.25% Tween-20 (TTBS) then
probed overnight with an anti-IL-2 antibody. After washing with
TTBS, bound antibody was detected with a horseradish perox-
idase conjugated anti-rabbit secondary antibody (Abcam) in
TTBS. The blots were developed using enzyme chemilumines-
cence (Pierce Biotechnology, Rockford, IL) and blue X-ray film
(Phenix, Hayward, CA).
Western blot analysis of aortic tissues was performed by first
mincing the tissue into pieces, rinsing the pieces in PBS, and then
homogenizing the minced tissue in ice-cold 4 M urea buffer
(100 ml buffer/mg tissue) containing 0.05% Triton X-100 v/v and
1 mM PMSF. The homogenate was sonicated on ice followed by
centrifugation to remove insoluble material. The resulting
supernatant (extract) was collected, and the protein concentration
measured by DC protein assay (Bio-Rad). A 25 mg aliquot was
then mixed with an equal volume of 2X Laemmli running buffer
containing 5% v/v b-mercaptoethanol. The samples were then
Cytotoxicity of Dimeric IL-2
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analyzed by Western blot as described. Blots analyzing tissues from
mice injected with dye-labeled IL-2 were visualized using an
Odyssey infrared imager (LI-COR Biosciences).
Heparinase digestion of tissues
Heparinase I digestion of tissues (spleen, aorta) from Balb/c
mice injected with dye-labeled IL-2 was performed by incubating
approximately 6, 262 mm, pieces of aorta or spleen in digestion
buffer (0.03 M Tris-HCl, 3.3 mM calcium acetate, 6 mM sodium
acetate, pH 7.0] containing 1 mM PMSF) to which 2 U
heparinase I was added and incubated at 37uC for approximately
18 h. The vessel tissue was pelleted by centrifugation and the
resultant supernatant collected and total protein present deter-
mined by DC protein assay (Bio-Rad). A 50 mg aliquot was mixed
with an equal volume of 2X Laemmli running buffer (Bio-Rad)
containing 5% v/v b-mercaptoethanol, separated by SDS-PAGE,
transferred to nitrocellulose, then visualized on an Odyssey
infrared imager (LI-COR Biosciences) or probed with anti-IL-2
antibodies.
MALDI Analysis
To facilitate MALDI analysis of the 30 kD dimer isolated from
EL4-conditioned media, samples of the dimer (25–40 mg) purified
by elution from preparative SDS-PAGE (see above) were
deglycosylated by treatment with N-glycanase (PNGase-F), O-
glycanase, and sialidase as per the manufacture’s instructions
(GlycoPro Enzymatic Deglycosylation Kit, Prozyme, Hayward,
CA). The deglycosylated samples were then subjected to iso-
electric focusing on ampholine strips with a pH gradient of 5–8
(Bio-Rad). Multiple focusing strips were run concomitantly
followed again by SDS-PAGE permitting some gels to be stained
with Coomassie R-250 while others were processed for Western
blot analysis with an anti-IL-2 antibody (see above). Using this
methodology, focused spots with IL-2 immunoreactivity were
Figure 1. A 30 kD form of IL-2 is present in murine aortas and released by heparinase digestion. (A) Balb/c mice were given 1 mg
infrared-IL-2 daily by intraperitoneal injection for 8 doses, and sacrificed 3 days following the last dose. Tissues were processed as described for
Western blot analysis, and analyzed on an Odyssey infrared scanner. Results shown are representative of 10 experiments. ‘‘IL-2’’ denotes dye-labeled
IL-2 prior to injection. (B) Balb/c mice were given a single dose of 1.5 mg infrared-IL-2, and sacrificed 2.5 days later. Five 1 mm long pieces of murine
aortas were incubated at 37uC with 2 U heparinase I or heparinase buffer for 18 h, and the released material was separated by SDS-PAGE and
analyzed on an Odyssey infrared scanner. Results shown are representative of 2 experiments. IL-2 was labeled with infrared dye as described in
Materials and Methods. (C) Murine spleens, aortas, or kidneys were homogenized, processed for Western blot analysis, and probed with anti-IL-2
antibodies. Results shown are representative of 5 experiments. (D) Murine aortas were digested with heparinase I or buffer alone as above, processed
for Western blot analysis, and probed with anti-IL-2 antibodies. Note that dimeric IL-2 appears as a doublet. Results shown are representative of 5
experiments. (E) EL-4 cell supernatants were processed for Western blot analysis and probed with anti-IL-2 antibodies. Results shown are
representative of 10 experiments.
doi:10.1371/journal.pone.0102191.g001
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identified on the Coomassie-stained gels and excised. The gel
pieces were dehydrated by immersion in NaHCO3:acetonitrile
(1:1) containing 10 mM DTT, and 55 mM iodoacetamide. The
reduced-alkylated samples were re-hydrated with NaHCO3 buffer
and digested overnight at 37uC with 300 ng of sequencing grade
porcine trypsin (Promega). The next day, the supernatants were
removed and saved and the gel slices extracted 3X with 50%
acetonitrile containing 0.3% TFA v/v. The supernatants were
combined, lyophilized to a volume of ,10 mL, and concentrated
using C18 ZipTips (Millipore, Billerica, MA), that were eluted
with 95% acetonitrile containing 0.3% TFA v/v. The eluates were
then mixed with CHCA matrix (Thermo) and spotted onto a
brushed-steel MALDI target plate. Samples were analyzed using a
Bruker Autoflex III MALDI-TOF/TOF MS incorporating Bruker
LIFT and collision-induced dissociation (CID) fragmentation to
generate the protein/peptide sequence for peaks of interest. All
data was analyzed by searching the MASCOT server at the
Wright State University Proteome Analysis Laboratory.
Statistics
Software used for statistical analyses was the R library
‘‘multicomp’’. Specific analyses performed are noted in the figure
legends.
Results
Dimeric form of IL-2 is present in blood vessels
Recent work from our laboratory demonstrated that IL-2 is
present in blood vessels and is retained there by association with
heparan sulfate (HS) [8,9]. This observation was confirmed, in
part, by the systemic administration of infrared-dye labeled IL-2 to
Balb/c mice and subsequent recovery of this IL-2 from aortic
tissues. The infrared monomeric IL-2, with a MW of approxi-
mately 15 kD, was present in aortic tissue homogenates and was
released by incubation of aortic tissues with bacterial heparinase I.
Interestingly, a 30 kD labeled band was also present in the
homogenates and was released by heparinase digestion
(Figures 1A, B). Western blot analysis of murine aortic tissues
also revealed bands, recognized by anti-IL-2 antibodies, at 15 and
30 kD. These bands were present in both homogenates and in
supernatants from heparinase-treated tissue (Figures 1C, D).
Sampling of select tissues, including spleen and kidney, revealed
the presence of monomeric and dimeric IL-2 in homogenates
(Figure 1C and not shown).
We then asked whether a simplified, in vitro system such as IL-2
producing cells in culture would generate dimeric IL-2. To this
end, EL4.IL-2 cells, a subline producing large amounts of IL-2,
were stimulated and supernatants assessed for dimeric IL-2. Both
monomeric and dimeric IL-2 were present in supernatants of
activated EL-4 cells (Figure 1E). In addition, transglutaminase,
noted by Eitan, et al to be important for generating dimeric IL-2,
was present in EL4 supernatants by Western blot analysis (not
shown). In turn, the c-glutamyl-e-lysine epitope, characteristic of
transglutaminase-mediated cross-linking, was present in dimeric
IL-2 isolated from EL4 supernatants (not shown).
These results suggested that a dimeric form of IL-2 was present
in murine tissues. A review of the literature revealed that a dimeric
form of IL-2 had previously been identified in the conditioned
media of injured fish optic neurons [5,6,7] and that this dimeric
form of IL-2 induced apoptosis in oligodendrocytes. Given this
information, we sought to confirm that this 30 kD band was a
dimeric form of IL-2.
Figure 2. Isolation process does not impact function of IL-2. Recombinant murine IL-2 was isolated in a fashion identical to that used for
dimeric IL-2 (eluted IL-2). The proliferative response of CTLL-2 cells to ‘‘eluted IL-2’’ vs IL-2 (taken directly from the vial) was then compared by
measuring total ATP content. Results shown are the means 6 SD of triplicate wells, and are representative of 3 experiments.
doi:10.1371/journal.pone.0102191.g002
Cytotoxicity of Dimeric IL-2
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Isolation of dimeric IL-2
Our first step in confirming the presence of a dimeric form of
IL-2 was to develop a method for its isolation. Murine aortic
tissues or conditioned media from stimulated EL4.IL-2 cells was
used as a source of dimeric IL-2. Murine aortic tissues were
homogenized in urea, clarified by centrifugation, and the resulting
supernatants separated by SDS-PAGE. Supernatants from media
of the IL-2 producing lymphoma cells were concentrated and then
similarly separated. Companion gels were run for Western blot
analysis and zinc-staining. Bands of 15 kD and 30 kD, recognized
by a chicken anti-IL-2 polyclonal antibody (Sigma), were excised
from the companion zinc-stained gel and electro-eluted. Eluted
samples were dialyzed, and the presence of dimeric IL-2 verified
by Western blot. Samples of each eluted preparation separated by
SDS-PAGE and stained with Coomassie R250 showed the
presence of one band per sample.
To ensure that the isolation process was not influencing activity,
commercial IL-2 was subjected to the same isolation process as
described above. As seen in Figure 2, commercial IL-2 and
‘‘eluted’’ commercial IL-2 yielded identical proliferative responses
when assayed using an IL-2 dependent cell line, suggesting that the
isolation process had no effect on biological activity.
MALDI analysis of the 30 kD band from EL4 conditioned
media confirms the isolation of dimeric IL-2
Our efforts at MALDI analysis of the 30 kD dimer focused on
supernatants of murine lymphoma (EL4) cells since these
supernatants were less complex than tissue extracts and could be
generated in copious amounts. Following fragmentation of the
30 kD dimer (isolated per Methods), MS/MS analysis identified
four peaks consisting of 15 to 24 amino acids that were identified
as belonging to murine IL-2 (p#0.05) (Table 1). These peaks
yielded a combined score of 356 to confirm the identity as murine
IL-2 (Table 1; Figure 3A and B). Sequence coverage of 33.1% was
confined to the C-terminal portion of the protein with overlap of 2
of the peptides at a site between 82 and 101 amino acids
(Figure 3B).
Dimeric IL-2 is cytotoxic to multiple cell types
We next sought to determine whether the function of dimeric
IL-2 was similar to or different than the monomeric form. Given
the work by Eitan, et al, we focused on the potential cytotoxicity of
dimeric IL-2. Since we identified dimeric IL-2 in arterial tissues,
and previously demonstrated that VSMC express IL-2Rb [8] we
asked whether dimeric IL-2 was cytotoxic to VSMC. To this end,
dimeric IL-2 was isolated from murine aortas or EL-4 culture
media as described above. Increasing concentrations of dimeric
IL-2 were added to cultures of VSMC isolated from human aortas.
Cytotoxicity was assessed by release of lactate dehydrogenase
(LDH). As seen in Figure 4A, dimeric IL-2 induced rapid cell
death of VSMC in a dose-dependent fashion. Given this response,
we asked if dimeric IL-2 was cytotoxic to other cell types. Dimeric
IL-2 was cytotoxic to several cell types expressing the IL-2R,
including human and rat kidney epithelial cells [12,13], human
and murine melanoma cells [14,15], murine lymphocytes, murine
lymphoma cells, human leukemia cells, and human colon
carcinoma cells [16] (Figure 4B–D and not shown). Of note,
neither eluted monomeric IL-2 up to 1000 ng/ml, nor the eluate
from an empty gel slice, were cytotoxic (see Figure 4 legend).
Given these results, we asked whether recombinant, murine IL-
2 could be used to generate a cytotoxic dimer. Using transgluta-
minase, commercially available monomeric IL-2 was provided as a
substrate to generate cross-linked 30 kD dimers, which were then
isolated as previously described. Dimeric IL-2 originating from
bacterial sources, and therefore not glycosylated, was not
cytotoxic. Similarly, dimeric IL-2 originating from insect sources
(less complex than mammalian glycosylation [17]) also lacked
cytotoxicity. Together, these results suggest that glycosylation
contributes to the cytotoxicity of dimeric IL-2.
The results of the LDH release assay demonstrated that dimeric
IL-2 kills cells rapidly. To obtain a more precise measure of this
effect, especially at early time points, we evaluated cell death using
a fluorescent reagent that binds DNA and is designed to assess cell
death kinetically. As seen in Figures 5A and B, the onset of cell
death was very rapid; half of the maximal fluorescence induced by
dimer-mediated cytotoxicity was reached approximately 10
minutes after exposing VSMCs to dimeric IL-2.
The rapidity of dimer-induced cell death suggested that the
mechanism might involve oncosis rather than apoptosis, since
apoptosis typically occurs over hours rather than minutes. Phase
contrast microscopy of kidney epithelial cells exposed to dimeric
IL-2 for 30 minutes revealed membrane blebbing consistent with
an oncotic form of cell death (Figure 5C).
Inhibition of dimer-mediated cytotoxicity
To begin to address the mechanism of dimer-induced cell death,
we first asked whether anti-IL-2 antibodies could inhibit dimer-
mediated cytotoxicity. For these studies we chose S4B6, a well-
described anti-IL-2 antibody known to neutralize IL-2-mediated
proliferation [18]. As seen in Figure 6A, incubation of the dimer
Figure 3. MALDI MS/MS spectra of 4 peaks derived from the tryptic digest of the 30 kD band isolated from EL-4 conditioned media.
MS/MS analysis of 30 kD dimer isolated from EL4-conditioned media identified four peaks consisting of 15 to 24 amino acids that yielded a combined
score of 356 confirming they came from murine IL-2 (p 0.05).
doi:10.1371/journal.pone.0102191.g003
Table 1. MALDI-TOF/TOF analysis of the 30 kD band produced by EL-4 T lymphoma cells and recognized by an anti-IL-2 antibody.
Observed Expected Theoretical Score Peptide
1557.6212 1556.6139 1556.7504 115 K.DLQCLEDELGPLR.H
1782.7065 1781.6993 1781.8584 123 K.SFQLEDAENFISNIR.V
2227.9432 2226.9360 2227.1154 49 K.QATELKDLQCLEDELGPLR.H
2551.8858 2550.8786 2551.0809 70 K.GSDNTFECQFDDESATVVDFLR.R
IL2_MOUSE Mass: 19616 Score: 356 Queries matched: 4.
Sequence Coverage: 33.1%, pI 4.7.
doi:10.1371/journal.pone.0102191.t001
Cytotoxicity of Dimeric IL-2
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with S4B6 blocked dimer-mediated cell cytotoxicity in a dose-
dependent fashion. This result suggests that the peptide sequence
within IL-2 that mediates proliferation is exposed in the dimeric
form and is likely important for dimer-mediated cytotoxicity.
We next asked whether interference with the IL-2 receptor
would alter dimer-mediated cell death. Little information exists
about the expression of the IL-2 receptor in VSMCs. Previous
studies from our laboratory indicate that these cells express at least
the b portion of the IL-2 receptor [8]. To assess the role of the IL-
2R in dimeric IL-2 mediated cell death, we pre-incubated human
VSMCs with a polyclonal anti-IL2Rb antibody and then exposed
them to dimeric IL-2. As seen in Figure 6B, pre-incubation with
anti IL-2Rb antibodies inhibited dimer-mediated cell death in a
dose dependent fashion, suggesting that dimer-mediated cell death
occurs through association with IL-2Rb. Similar results were
obtained in rat kidney epithelial cells using a monoclonal anti-rat
anti-IL2Rb antibody (Figure 6C) and melanoma cells (not shown).
Whether the a and c portions of the IL-2R are also involved in
dimer-mediated cell death is currently under investigation.
Discussion
This report demonstrates, for the first time, the identification
and isolation of a dimeric form of IL-2 from mammalian tissues.
The cytotoxicity of dimeric IL-2 stands in stark contrast to the
proliferative and survival functions of the monomer. This finding
leads to several questions concerning the function and regulation
of the dimeric form.
While the proliferative properties of IL-2 have been recognized
since its discovery, the importance of IL-2 in cell death was
revealed after the generation of IL-2 knockout mice, which
develop a lymphoproliferative disorder [4]. At approximately the
Figure 4. Dimeric IL-2 is cytotoxic to multiple cell types. Dimeric IL-2, isolated from murine aortas or conditioned media from EL-4 T
lymphoma cells were added to cultures of (A) primary human vascular smooth muscle cells, (B) normal rat kidney cells (NRK cell line), (C) human renal
epithelial cells (HK-2 cell line), (D) murine melanoma cells (B16-F10). The cells were incubated for 2 h with increasing concentrations of dimeric IL-2.
Cytotoxicity was assessed by release of LDH and expressed as % lysis (experimental/total lysis x 100). Smooth muscle cells cultured under identical
conditions with either 1000 ng/ml eluted, commercial, murine IL-2 or eluate from an empty gel slice each yielded a % lysis of 2.9%, and 3.2%
respectively. Results shown are the means 6 SD of triplicate wells, and are representative of 5–20 experiments. Percent lysis is significantly different
across the 4 concentrations of dimeric IL-2 in each figure (A–D, p = 4.861027, p = 3.261027, p = 161024, p = 1.8610210, by ANOVA).
doi:10.1371/journal.pone.0102191.g004
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same time, IL-2 was shown to induce apoptosis when activated T
cells were exposed to antigen and IL-2 [2]. Activation-induced cell
death, mediated by IL-2, was therefore identified as a mechanism
through which IL-2 induces cell death [19]. In light of our
findings, we suggest that dimeric IL-2 also contributes to IL-2-
mediated cell death in vivo.
During an immune response, activated T cells produce both
glycosylated and non-glycosylated IL-2. In vitro studies have
shown that the ratio of glycosylated to non-glycosylated IL-2
produced by human peripheral blood lymphocytes depends on the
stimulus and duration of stimulation [20]. In the study by
Conradt, et al, human peripheral blood lymphocytes stimulated
with A23187 and PMA initially produced non-glycosylated IL-2,
and only produced glycosylated IL-2 30–40 h after stimulation.
Glycosylation of IL-2 appears to be important since both
unglycosylated (bacterial) and simply glycosylated (insect) forms
of dimeric IL-2, generated from recombinant sources, are not
cytotoxic. Whether glycosylation contributes to conformation of
the dimer, binding to the receptor, or other, is not known. The
role of glycosylation in dimer-mediated cell death is currently
under investigation.
The presence or absence of glycosylation likely represents one
means by which the cytotoxicity of dimeric IL-2 is controlled. The
aforementioned in vitro data suggests one possible scenario. In
vivo, T cells activated by foreign antigen initially produce non-
glycosylated IL-2. As the immune response proceeds, glycosylated
IL-2 is produced, resulting in the generation of cytotoxic, dimeric
IL-2 that kills IL-2R+ cells and restricts their excess accumulation.
Alternatively, the later production of glycosylated IL-2 may serve
to replenish stores released by heparanase earlier in the immune
response.
The potency of dimeric IL-2 suggests that it is tightly regulated
in vivo. In addition to glycosylation, other mechanisms to control
dimeric IL-2 include IL-2R expression, heparanase expression,
and the presence/absence of transglutaminase. Our results
indicate that antibodies recognizing IL-2Rb block the cytotoxicity
of dimeric IL-2. Interestingly, IL-2Rb also dimerizes, and this
property may facilitate association with dimerized IL-2 [21].
Studies addressing whether IL-2Ra or c are involved in the
cellular response to dimeric IL-2 are in progress.
Although produced by most mammalian cells, heparanase is
tightly controlled by several mechanisms, including (1) regulated
secretion, (2) uptake of secreted heparanase by low-density
lipoprotein-related receptor protein [22] and syndecan-4 [23],
and (3) expression, in that only one functional isoform of
mammalian heparanase has been identified [16]. Since dimeric
Figure 5. Dimeric IL-2 induces rapid onset of cell death. (A, B) CellTox Green dye was added to cultured VSMC followed by increasing
concentrations of dimeric IL-2 isolated from murine aortas (A) or EL4 media (B). Tissue culture plates were immediately placed in the microplate
reader and excited at 485 nm per manufacturer’s instructions. Cells were lysed, as a positive control, using a proprietary lysis buffer (Roche). In part A,
100 ng/ml and 50 ng/ml are significantly different than 0 ng/ml (p = 161024 for each, by Dunnett’s test for multiple comparisons). In part B, 20 ng/ml
and 10 ng/ml are significantly different than 0 ng/ml (p = 161024 for each, by the same analysis). (C) Normal rat tubular epithelial cells (NRK-52E)
were cultured for 30 minutes with 20 ng/ml dimeric IL-2, 40 ng/ml monomeric IL-2, or PBS. Scale bar: 50 mm. Results are representative of 10
experiments.
doi:10.1371/journal.pone.0102191.g005
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IL-2 is released by heparanase, tight control of heparanase
expression would, in turn, regulate the release of dimeric IL-2.
Whether other matrix-degrading enzymes, such as matrix-
metalloproteinases, release dimeric IL-2 is currently under
investigation.
Studies by our laboratory and Eitan, et al, indicate that
cytotoxic, dimeric IL-2 is generated by transglutaminase-mediated
crosslinking of monomeric IL-2. Transglutaminases are ubiqui-
tous, well-described cross-linking enzymes known to alter the
functions of proteins through oligomerization. Probably the best-
studied example is the crosslinking of fibrinogen or fibrin [24] in
the formation of blood clots. Other examples include the
dimerization of osteopontin, which increases its adhesivity to
osteoclasts as compared to the monomer [25], and the oligomer-
ization of sonic hedgehog, which increases its bioactivity as a
morphogen [26]. The functional differences conferred by dimer-
ization of IL-2, however, may represent one of the most distinct,
transglutaminase-mediated changes in a biologically active pro-
tein.
Our finding that dimeric IL-2 is cytotoxic to several parenchy-
mal cell types begs the question as to its function in vivo with
respect to these cells. Given that dimeric IL-2 is released by
heparanase and cross-linked by enzymes such as transglutaminase,
its presence in vivo may be limited to or concentrated in areas of
injury or inflammation. Because dimeric IL-2 appears to
precipitate a necrotic vs apoptotic cell death, we anticipate that
dimeric IL-2 would serve to propagate inflammation.
In summary, our laboratory has identified a dimeric form of IL-
2 present in mammalian tissues. This form of IL-2 causes a very
rapid cell death, which appears to be oncotic rather than
apoptotic. These findings yield several questions regarding the
mechanism of cell death mediated by dimeric IL-2, its regulation,
and the contribution of dimeric IL-2 to cellular homeostasis in
both immune and non-immune systems. These answers, as they
unfold, may dramatically alter our perception of how IL-2
functions in vivo.
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